Patent details

EP2948479 Title: EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS

Basic Information

Publication number:
EP2948479
PCT Application Number:
US2014012107
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP147404446
PCT Publication Number:
WO2014113712
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS
French Title of Invention:
ÉVALUATION ET TRAITEMENT DE TROUBLES MÉDIÉS PAR LA BRADYKININE
German Title of Invention:
UNTERSUCHUNG UND BEHANDLUNG VON BRADYKININVERMITTELTEN ERKRANKUNGEN
SPC Number:

Dates

Filing date:
17/01/2014
Grant date:
01/08/2018
EP Publication Date:
02/12/2015
PCT Publication Date:
24/07/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
01/08/2018
EP B1 Publication Date:
01/08/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
17/01/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
21/06/2021
 
 

Name:
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Address:
1-1, DOSHOMACHI 4-CHOME, CHUO-KU, OSAKA-SHI, OSAKA 541-0045, Japan (JP)

History of Owners

From:
25/07/2018
To:
21/06/2021

Name:
Dyax Corp.
Address:
300 Shire Way, Lexington, MA 02421, United States (US)

Agent

Name:
ARONOVA S.A.
From:
02/11/2018
Address:
PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
TENHOOR, Christopher
Address:
United States (US)

2

Name:
FAUCETTE, Ryan
Address:
United States (US)

3

Name:
CONLEY, Greg
Address:
United States (US)

4

Name:
CHYUNG, Yung
Address:
United States (US)

5

Name:
SEXTON, Daniel, J.
Address:
United States (US)

6

Name:
ADELMAN, Burt
Address:
United States (US)

7

Name:
NIXON, Andrew
Address:
United States (US)

8

Name:
KENNISTON, Jon, A.
Address:
United States (US)

Priority

Priority Number:
201361754607 P
Priority Date:
20/01/2013
Priority Country:
United States (US)

Classification

IPC classification:
C07K 16/40;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2021/08
Publication date:
01/07/2021
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

1

Issue number:
201831
Publication date:
01/08/2018
Description:
Grant (B1)

2

Issue number:
201836
Publication date:
05/09/2018
Description:
Application number/publication number of the divisional application (Art. 76) changed

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20210000252A
Date Registered:
21/06/2021
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
Baker & McKenzie
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Address:
1-1, DOSHOMACHI 4-CHOME, CHUO-KU, OSAKA-SHI, OSAKA 541-0045, Japan (JP)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
02/02/2026
Annual Fee Number:
13
Annual Fee Amount:
180 Euro
Expected Payer:
Last Annual Fee Payment Date:
18/12/2024
Last Annual Fee Paid Number:
12
Last Annual Fee Paid Amount:
165 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages
08/11/2018 Outgoing Correspondence 1
21/06/2021 Request For Change 6
22/06/2021 Outgoing Correspondence 2
02/11/2018 Power Of Attorney 1